Success Metrics

Clinical Success Rate

76.9%

Based on 10 completed trials

Completion Rate

77%(10/13)

Active Trials

3(16%)

Results Posted

70%(7 trials)

Terminated

3(16%)

Phase Distribution

Ph phase_3

Ph phase_4

11%

Ph phase_1

16%

Ph not_applicable

47%

Ph phase_2

21%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution19 total trials

Phase 1Safety & dosage

3(15.8%)

Phase 2Efficacy & side effects

4(21.1%)

Phase 3Large-scale testing

1(5.3%)

Phase 4Post-market surveillance

2(10.5%)

N/ANon-phased studies

9(47.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

10 of 14 finished

Non-Completion Rate

28.6%

4 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(10)

Terminated(4)

Other(1)

Detailed Status

Completed10

Recruiting3

Terminated3

unknown1

Withdrawn1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

76.9%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (15.8%)

Phase 24 (21.1%)

Phase 31 (5.3%)

Phase 42 (10.5%)

N/A9 (47.4%)

Trials by Status

completed1053%

unknown15%

withdrawn15%

recruiting316%

not_yet_recruiting15%

terminated316%

Recent Activity

3 active trials

Showing 5 of 19

recruitingnot_applicable

Maternal Oxygen Supplementation for Intrauterine Resuscitation

NCT05681624

not_yet_recruitingphase_1

A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia

NCT06327373

completednot_applicable

Clinical Trials (19)

Showing 19 of 19 trials

NCT05681624Not Applicable

Maternal Oxygen Supplementation for Intrauterine Resuscitation

Recruiting

NCT06327373Phase 1

A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia

Not Yet Recruiting

NCT05473000Not Applicable

Susceptibility of Cardiorespiratory Responses to Ozone During Cycling Exercise

Completed

NCT06118567Phase 2

Effect of Nitrous Oxide on Aggression.

Recruiting

NCT05094271Phase 1

Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease?

Recruiting

NCT03745898Phase 3

The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea

Terminated

NCT02741284Not Applicable

Oxygen for Intrauterine Resuscitation of Category II Fetal Heart Tracings

Completed

NCT03996317Not Applicable

Maternal Hyperoxygenation for Intrapartum Fetal Heart Rate Tracing Abnormalities

Withdrawn

NCT03847922Phase 4

Nitrous Oxide for Analgesia During Office Urethral Bulking

Terminated

NCT03745092Not Applicable

The Efficacy of Normobaric Oxygen on Chronic Cerebral Ischemia

Completed

NCT00414726Phase 2

Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial

Terminated

NCT03141697Not Applicable

The Use of CO2 in Routine-Colonoscopy

Completed

NCT01542307Phase 2

Normobaric Oxygen (NBO) Therapy in Acute Migraine

Completed

NCT01633827Not Applicable

Combination Therapy to Treat Sleep Apnea

Completed

NCT01781793Not Applicable

Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease

Completed

NCT01423929Phase 4

Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion

Completed

NCT01499316Not Applicable

Investigating the Effects of Hyperoxia on Fractional Flow Reserve

Unknown

NCT01272349Phase 1

Intermittent Hypoxia Elicits Prolonged Restoration of Motor Function in Human SCI

Completed

NCT01427192Phase 2

Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension

Completed

All 19 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 19